Playback speed
10 seconds
Oral Abstract NHL 122: Durability of Response in Patients With Refractory Large B Cell Lymphoma Treated With Axicabtagene Ciloleucel in the Pivotal Phase 2 Study, ZUMA-1
18 views
October 25, 2018
Login to view comments.
Click here to Login